Figure 1
Comparison of (a) ASCVD and (b) all cause death after KT by rituximab induction in the matched cohort. KT, kidney transplantation; ASCVD, atherosclerotic cardiovascular disease.
Figure 1 | Scientific Reports
Comparison of (a) ASCVD and (b) all cause death after KT by rituximab induction in the matched cohort. KT, kidney transplantation; ASCVD, atherosclerotic cardiovascular disease.
